A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice.
BACKGROUND
In 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an adenovirus-based influenza H1N1 vaccine tested for immunogenicity and efficacy to confer protection in animal model.


METHODS
We generated two adenovirus(Ad5)-based influenza vaccine candidates encoding the wildtype or a codon-optimized hemagglutinin antigen (HA) from the recently emerged swine influenza isolate A/California/04/2009 (H1N1)pdm. After verification of antigen expression, immunogenicity of the vaccine candidates were tested in a mouse model using dose escalations for subcutaneous immunization. Sera of immunized animals were tested in microneutalization and hemagglutination inhibition assays for the presence of HA-specific antibodies. HA-specific T-cells were measured in IFNgamma Elispot assays. The efficiency of the influenza vaccine candidates were evaluated in a challenge model by measuring viral titer in lung and nasal turbinate 3 days after inoculation of a homologous H1N1 virus.


CONCLUSIONS
A single immunization resulted in robust cellular and humoral immune response. Remarkably, the intensity of the immune response was substantially enhanced with codon-optimized antigen, indicating the benefit of manipulating the genetic code of HA antigens in the context of recombinant influenza vaccine design. These results highlight the value of advanced technologies in vaccine development and deployment in response to infections with pandemic potential. Our study emphasizes the potential of an adenoviral-based influenza vaccine platform with the benefits of speed of manufacture and efficacy of a single dose immunization.
Steitz
Julia
J
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Barlow
Peter G
PG
Hossain
Jaber
J
Kim
Eun
E
Okada
Kaori
K
Kenniston
Tom
T
Rea
Sheri
S
Donis
Ruben O
RO
Gambotto
Andrea
A
D000818:Animals; D045744:Cell Line, Tumor; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007109:Immunity / Q000276:immunology*; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009976:Orthomyxoviridae Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D015203:Reproducibility of Results
D007252:Influenza Vaccines
J Virol. 2009 May;83(10):5192-203
19279103
Mol Ther. 2009 Aug;17(8):1333-9
19513019
Virology. 2004 Aug 15;326(1):57-66
15262495
Mol Ther. 2008 May;16(5):965-71
18301400
J Virol. 2007 Sep;81(17):9556-9
17596315
J Virol. 2007 Nov;81(21):11560-8
17715243
J Infect Dis. 2005 Apr 15;191(8):1216-20
15776365
Gene Ther. 2003 Nov;10(23):1941-9
14528318
Nature. 2009 Jun 25;459(7250):1122-5
19516283
J Clin Virol. 2009 Jul;45(3):169-73
19540800
Curr Protoc Microbiol. 2006 Dec;Chapter 15:Unit 15G.1
18770580
Vaccine. 2005 Jan 11;23(8):1029-36
15620476
Nature. 2002 Jan 17;415(6869):331-5
11797011
Nature. 2009 Jun 18;459(7249):931-9
19525932
N Engl J Med. 2009 Jun 18;360(25):2605-15
19423869
Virology. 2007 Sep 15;366(1):166-73
17524441
Nature. 2009 Aug 20;460(7258):1021-5
19672242
Hum Gene Ther. 1996 Aug 20;7(13):1515-25
8864752
J Virol. 1997 Mar;71(3):1842-9
9032314
Vaccine. 2007 Oct 10;25(41):7271-9
17825960
J Virol. 2001 Dec;75(23):11603-13
11689642
Science. 2009 Jul 10;325(5937):197-201
19465683
J Virol. 2001 Mar;75(5):2462-7
11160750
Clin Infect Dis. 2009 May 1;48(9):1254-6
19323631
J Virol. 2006 Feb;80(4):1959-64
16439551
Nature. 2009 Apr 30;458(7242):1082-3
19407756
Lancet. 2006 Feb 11;367(9509):475-81
16473124
Science. 2000 Oct 20;290(5491):486-92
11039923
N Engl J Med. 2009 Dec 17;361(25):2405-13
19745216
J Clin Microbiol. 1999 Apr;37(4):937-43
10074505
Clin Diagn Lab Immunol. 2004 Mar;11(2):351-7
15013987
Science. 2009 May 1;324(5927):572-3
19407164
Vaccine. 2004 Jun 30;22(20):2586-98
15193384
Biotechnol Prog. 2004 Mar-Apr;20(2):443-8
15058988